Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Pilot Survey of Governmental Funding Agencies and the Financial Industry-Reference-Cited by-同舟云学术

Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Pilot Survey of Governmental Funding Agencies and the Financial Industry

Published:2012-11 Issue:21-22 Volume:18 Page:2187-2194
ISSN:1937-3341
Container-title:Tissue Engineering Part A
language:en
Short-container-title:Tissue Engineering Part A

Author:

Bertram Timothy A.¹,Tentoff Edward²,Johnson Peter C.³⁴,Tawil Bill⁵⁶,Van Dyke Mark⁷,Hellman Kiki B.⁸

Affiliation:

1. President and CSO, Research and Development, Tengion, Inc., Winston-Salem, North Carolina.

2. Managing Director, Piper Jaffray Company, New York, New York.

3. Vice President, Research and Development, Avery Dennison Medical Products Division, Chicago, Illinois.

4. President and CEO, Scintellix, LLC, Raleigh, North Carolina.

5. Director, Global Expansion, Baxter Biosurgery, Westlake Village, California.

6. Bioengineering Department, UCLA, Los Angeles, California.

7. Wake Forest Institute of Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

8. President and CEO, The Hellman Group, LLC, Clarksburg, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biomaterials,Biochemistry,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tea.2012.0186

Reference10 articles.

1. Hurdles in Tissue Engineering/Regenerative Medicine Product Commercialization: A Survey of North American Academia and Industry

2. Challenges in Tissue Engineering and Regenerative Medicine Product Commercialization: Building an Industry

3. Great Expectations: Private Sector Activity in Tissue Engineering, Regenerative Medicine, and Stem Cell Therapeutics

4. Tissue Engineering: The End of the Beginning

5. Private Sector Development of Stem Cell Technology and Therapeutic Cloning

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long and winding road towards payment for healthcare innovation with high societal value but limited commercial value: A comparative case study of devices and health information technologies;Technology in Society;2023-11

2. Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care;Pharmaceutics;2023-01-04

3. Does acquisition lead to the growth of high-tech scale-ups? Evidence from Europe;Research in International Business and Finance;2023-01

4. Commercialization and regulation of regenerative medicine products: Promises, advances and challenges;Biomedicine & Pharmacotherapy;2022-09

5. Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital;Cells;2022-03-17